AfriNEXT

AfriNEXT project aims to develop and promote a vibrant, strong and sustainable research culture Africa. The project will create a critical mass of African world-class researchers capable of carrying out

Ebola vaccines at a la glance

Ebola vaccine candidates are currently being evaluated in phase I–III clinical trials conducted in Africa, the EU and the US. Although preclinical development of candidate vaccines utilise different platforms, including

Response to Covid-19 in Africa

The impact of Covid-19 in Africa is a ticking bomb on which the European Union (EDCTP) intervenes by supporting research projects. In response to this, a consortium of African and